Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Astellas
Astellas
Astellas has menopause accelerated approval ambition thwarted by FDA at last minute
Fierce Biotech
Mon, 02/20/23 - 12:19 pm
Astellas
menopause
fezolinetant
FDA
ASCO GU: Pfizer touts Talzenna's strong showing in PARP prostate cancer battle with AstraZeneca, J&J
Fierce Pharma
Fri, 02/17/23 - 09:36 am
ASCO GU
Pfizer
Astellas
Xtandi
prostate cancer
Astellas buys Super Bowl commercial spot to raise menopause awareness
Medical Marketing and Media
Sun, 02/12/23 - 07:36 pm
Astellas
menopause
Super Bowl
DTC advertising
television ads
fezolinetant
Astellas Taps New CEO in Nod to Accelerated Growth
BioSpace
Mon, 02/6/23 - 10:56 am
Astellas
Pharma CEOs
Naoki Okamura
Sandoz signs deal for antifungal from Astellas in buff-up of anti-infectives portfolio
Endpoints
Wed, 01/25/23 - 10:44 am
Sandoz
Novartis
Astellas
antifungals
Mycamine
generics
Astellas, after years of gene therapy woes, gets rare boost with FDA lifting of Pompe clinical hold
Fierce Biotech
Fri, 01/20/23 - 10:24 am
Astellas
Pompe disease
gene therapy
AT845
ASCO-GI 2023 – zolbetuximab opens up a stomach cancer niche
EP Vantage
Fri, 01/20/23 - 10:19 am
ASCO-GI
zolbetuximab
cancer of the gastro-esophageal junction
Astellas
Lawmakers again urge the Biden administration to use federal law to widen access to a cancer drug
Stat
Wed, 01/11/23 - 10:51 am
cancer
oncology
Joe Biden
Astellas
Xtandi
prostate cancer
Astellas loses bid to block Lexiscan generics in US
Pharmaphorum
Wed, 01/4/23 - 05:15 pm
legal
Astellas
Pfizer
Lexiscan
patents
Astellas’ Phase III gastric cancer therapy trial meets primary endpoint
Clinical Trials Arena
Fri, 12/16/22 - 10:21 am
Astellas
clinical trials
zolbetuximab
gastric cancer
Astellas' $1.3B antibody strikes first in hot cancer field, extending survival in phase 3
Fierce Biotech
Thu, 11/17/22 - 10:37 am
Astellas
zolbetuximab
clinical trials
cancer
gastric cancer
What causes hot flashes? Astellas ramps up educational campaign ahead of FDA decision
Endpoints
Wed, 11/2/22 - 11:00 pm
Astellas
hot flashes
menopause
fezolinetant
patient education
String of gene therapy deals spurs cautious optimism on Wall Street
BioPharma Dive
Tue, 11/1/22 - 07:09 pm
gene therapy
M&A
Akouos
AGTC
Taysha Gene Therapies
Astellas
Eli Lilly
Syncona
Astellas Pays $50M for Access to Taysha's Rett, GAN Programs
BioSpace
Wed, 10/26/22 - 10:29 am
Taysha Gene Therapies
Astellas
gene therapy
Rett Syndrome
GAN
Astellas takes stake in gene therapy developer Taysha
BioPharma Dive
Mon, 10/24/22 - 11:12 pm
Astellas
Taysha Gene Therapies
gene therapy
Astellas, Pantherna add organ to mRNA tie-up; Rocket launches sale of six figures worth of stock
Endpoints
Wed, 10/5/22 - 10:41 am
Astellas
Pantherna
MRNA
ESMO: Seagen's Padcev pulls its weight in combo with Merck's Keytruda
Fierce Pharma
Thu, 09/8/22 - 04:40 pm
Merck
Keytruda
Astellas
Seagen
Padcev
ESMO
urothelial cancer
Astellas reports Phase III data of fezolinetant for menopause-linked VMS
Clinical Trials Arena
Tue, 09/6/22 - 10:50 am
Astellas
clinical trials
menopause
China
fezolinetant
vasomotor symptoms
hot flashes
Revealed: which pharma companies leading the way in artificial intelligence
Clinical Trials Arena
Fri, 08/26/22 - 10:37 am
artificial intelligence
Pfizer
Novartis
AstraZeneca
Johnson & Johnson
Bristol Myers Squibb
Takeda
GSK
Bayer
Astellas
Astellas' menopause therapy accepted for FDA review 5 months after late-phase study mars record
Fierce Biotech
Thu, 08/18/22 - 12:40 pm
Astellas
menopause
FDA
clinical trials
Asia
fezolinetant
hot flashes
Pages
« first
‹ previous
1
2
3
4
5
6
7
8
9
…
next ›
last »